**Yes** Agilon has a free trial.
Akilenza Injection (trade name: Recchio) is an autologous chimeric antigen receptor T cell immunotherapy (CAR-T) drug targeting CD19, used to treat relapsed or refractory Adult patients with refractory B-cell precursor ALL.
It is difficult to say whether CAR-T therapy is the ultimate solution for cancer patients, but what is certain is that it can indeed have a certain therapeutic effect, control tumors in some patients, or significantly prolong the treatment of cancer. patient survival.